• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利多卡因在多次服用美托洛尔预处理的健康个体中的药代动力学。

Pharmacokinetics of lidocaine in healthy individuals pretreated with multiple doses of metoprolol.

作者信息

Jordö L, Johnsson G, Lundborg P, Regårdh C G

出版信息

Int J Clin Pharmacol Ther Toxicol. 1984 Jun;22(6):312-5.

PMID:6746155
Abstract

The effect of pretreatment with multiple doses of 100 mg of metoprolol on the pharmacokinetics of lidocaine has been studied in six young healthy subjects. The lidocaine dose was 100 mg and the infusion time 12 minutes. Metoprolol had no effect on the levels or the time course of lidocaine in the plasma. The disposition characteristics of the antiarrhythmic agent were not significantly altered by metoprolol in these individuals. These results cannot be extrapolated to prolonged infusion of lidocaine in patients with myocardial infarction.

摘要

在六名年轻健康受试者中研究了多次给予100毫克美托洛尔预处理对利多卡因药代动力学的影响。利多卡因剂量为100毫克,输注时间为12分钟。美托洛尔对血浆中利多卡因的水平或时间进程没有影响。在这些个体中,美托洛尔并未显著改变抗心律失常药物的处置特征。这些结果不能外推至心肌梗死患者中利多卡因的长时间输注情况。

相似文献

1
Pharmacokinetics of lidocaine in healthy individuals pretreated with multiple doses of metoprolol.利多卡因在多次服用美托洛尔预处理的健康个体中的药代动力学。
Int J Clin Pharmacol Ther Toxicol. 1984 Jun;22(6):312-5.
2
Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.健康志愿者中性别对美托洛尔药代动力学和药效学的影响。
Clin Pharmacol Ther. 1999 Dec;66(6):594-601. doi: 10.1053/cp.1999.v66.103400001.
3
Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.美托洛尔控释片(倍他乐克缓释片)和普通片剂在健康志愿者体内的血浆浓度及药理作用
Int J Clin Pharmacol Ther Toxicol. 1980 Jul;18(7):292-7.
4
Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics.细胞色素P450 2D6超快代谢基因型对美托洛尔药代动力学和药效学的影响。
Clin Pharmacol Ther. 2004 Oct;76(4):302-12. doi: 10.1016/j.clpt.2004.07.002.
5
Lidocaine elimination: effects of metoprolol and of propranolol.利多卡因的消除:美托洛尔和普萘洛尔的影响。
Clin Pharmacol Ther. 1983 Feb;33(2):133-8. doi: 10.1038/clpt.1983.20.
6
Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.β1肾上腺素能受体的Gly389Arg多态性与美托洛尔的心血管反应相关。
Clin Pharmacol Ther. 2003 Oct;74(4):372-9. doi: 10.1016/S0009-9236(03)00224-8.
7
Modulation of metoprolol pharmacokinetics and hemodynamics by diphenhydramine coadministration during exercise testing in healthy premenopausal women.在健康绝经前女性运动试验期间,苯海拉明联合给药对美托洛尔药代动力学和血流动力学的影响。
J Pharmacol Exp Ther. 2005 Jun;313(3):1172-81. doi: 10.1124/jpet.104.081109. Epub 2005 Feb 17.
8
Airway topicalisation in morbidly obese patients using atomised lidocaine: 2% compared with 4%.使用雾化利多卡因对病态肥胖患者进行气道表面麻醉:2%与4%的比较。
Anaesthesia. 2007 Oct;62(10):984-8. doi: 10.1111/j.1365-2044.2007.05179.x.
9
Intranasally administered phenylephrine and blood pressure.经鼻给药的去氧肾上腺素与血压
Can Med Assoc J. 1982 Sep 1;127(5):365-8.
10
The reduction of lidocaine clearance by dl-propranolol: an example of hemodynamic drug interaction.dl-普萘洛尔降低利多卡因清除率:血流动力学药物相互作用的一个实例。
J Pharmacol Exp Ther. 1973 Feb;184(2):515-9.

引用本文的文献

1
Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.美托洛尔。对其药效学和药代动力学特性以及在高血压、缺血性心脏病和相关心血管疾病中的治疗效果的最新综述。
Drugs. 1986 May;31(5):376-429. doi: 10.2165/00003495-198631050-00002.
2
The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.利多卡因和β-肾上腺素受体拮抗剂在急性心肌梗死患者中的药代动力学。
Clin Pharmacokinet. 1987 Nov;13(5):293-316. doi: 10.2165/00003088-198713050-00002.
3
The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.
普萘洛尔对利多卡因清除率的损害——主要源于酶抑制作用。
Br J Clin Pharmacol. 1985 May;19(5):597-603. doi: 10.1111/j.1365-2125.1985.tb02686.x.